Shattuck Labs Inc

NASDAQ:STTK

1.51

-0.02 (-1.31%)

7:23:49 PM EDT: $1.75 +0.24 (+15.89%)

Market Cap (Intraday)	63.29M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.29 Million
Adjusted EPS	-$0.52

See more estimates

10-Day MA	$1.83
50-Day MA	$2.27
200-Day MA	$2.89

See more pivots

Shattuck Labs Inc Stock, NASDAQ:STTK

500 West 5th Street, Suite 1200, Austin, Texas 78701

United States of America

Phone: +1.512.900.4690

Number of Employees: 105

http://www.shattucklabs.com

Description

Shattuck Labs, Inc. engages in the research and development of dual-sided fusion proteins used for medical treatment of cancer and autoimmune disease. It primarily focuses on Agonist Redirected Checkpoint (ARC) and Gamma Delta T Cell Engagers (GADLEN) platforms. It develops a novel class of biologic medicines, capable of multifunctional activity, with potential applications in oncology and autoimmune diseases. The company was founded by Josiah C. Hornblower and Taylor Schreiber in 2016 and is headquartered in Austin, TX.